DCK Antikörper (AA 161-260)
Kurzübersicht für DCK Antikörper (AA 161-260) (ABIN514902)
Target
Alle DCK Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 161-260
-
Verwendungszweck
- Mouse monoclonal antibody raised against a partial recombinant DCK.
-
Sequenz
- WMNNQFGQSL ELDGIIYLQA TPETCLHRIY LRGRNEEQGI PLEYLEKLHY KHESWLLHRT LKTNFDYLQE VPILTLDVNE DFKDKYESLV EKVKEFLSTL
-
Kreuzreaktivität
- Human
-
Produktmerkmale
- Antibody Reactive Against Recombinant Protein.
-
Immunogen
- DCK (NP_000779, 161 a.a. ~ 260 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
-
Isotyp
- IgG2a
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Buffer
- In 1x PBS, pH 7.4
-
Handhabung
- Aliquot to avoid repeated freezing and thawing.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
-
-
-
: "The role of HuR in gemcitabine efficacy in pancreatic cancer: HuR Up-regulates the expression of the gemcitabine metabolizing enzyme deoxycytidine kinase." in: Cancer research, Vol. 69, Issue 11, pp. 4567-72, (2009) (PubMed).
-
: "The role of HuR in gemcitabine efficacy in pancreatic cancer: HuR Up-regulates the expression of the gemcitabine metabolizing enzyme deoxycytidine kinase." in: Cancer research, Vol. 69, Issue 11, pp. 4567-72, (2009) (PubMed).
-
- DCK (Deoxycytidine Kinase (DCK))
-
Andere Bezeichnung
- DCK
-
Hintergrund
-
Full Gene Name: deoxycytidine kinase
Synonyms: MGC117410,MGC138632 -
Gen-ID
- 1633
-
NCBI Accession
- NM_000788
Target
-